NutriSystem Inc. (NASDAQ:NTRI) – Equities research analysts at DA Davidson issued their Q2 2019 earnings per share (EPS) estimates for NutriSystem in a research note issued to investors on Wednesday, October 31st. DA Davidson analyst L. Weiser anticipates that the company will earn $0.98 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $36.00 target price on the stock. DA Davidson also issued estimates for NutriSystem’s Q3 2019 earnings at $0.62 EPS.
NutriSystem (NASDAQ:NTRI) last announced its quarterly earnings results on Tuesday, October 30th. The company reported $0.54 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.54. NutriSystem had a net margin of 8.06% and a return on equity of 44.33%. The firm had revenue of $159.30 million during the quarter, compared to analysts’ expectations of $164.18 million. During the same period in the prior year, the company earned $0.49 EPS. The firm’s revenue was up .8% on a year-over-year basis.
Other analysts have also recently issued reports about the stock. B. Riley upped their price target on shares of NutriSystem from $52.00 to $53.00 and gave the stock a “buy” rating in a research report on Tuesday, July 31st. Zacks Investment Research raised shares of NutriSystem from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research report on Thursday, August 2nd. Barrington Research reiterated a “hold” rating on shares of NutriSystem in a report on Wednesday, August 1st. BidaskClub upgraded shares of NutriSystem from a “sell” rating to a “hold” rating in a report on Saturday, October 13th. Finally, ValuEngine upgraded shares of NutriSystem from a “strong sell” rating to a “sell” rating in a report on Friday, October 12th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. NutriSystem presently has a consensus rating of “Hold” and a consensus target price of $45.57.
Shares of NutriSystem stock opened at $37.57 on Friday. NutriSystem has a twelve month low of $26.06 and a twelve month high of $55.10. The firm has a market cap of $982.25 million, a P/E ratio of 19.17, a price-to-earnings-growth ratio of 1.62 and a beta of 1.27.
A number of hedge funds have recently modified their holdings of NTRI. Principal Financial Group Inc. lifted its holdings in NutriSystem by 0.8% in the 1st quarter. Principal Financial Group Inc. now owns 250,443 shares of the company’s stock worth $6,749,000 after buying an additional 2,095 shares in the last quarter. Guggenheim Capital LLC lifted its holdings in NutriSystem by 8.3% in the 1st quarter. Guggenheim Capital LLC now owns 56,018 shares of the company’s stock worth $1,509,000 after buying an additional 4,308 shares in the last quarter. Xact Kapitalforvaltning AB acquired a new position in NutriSystem in the 2nd quarter worth $237,000. Independence Advisors LLC acquired a new stake in shares of NutriSystem in the 2nd quarter valued at about $203,000. Finally, Atria Investments LLC acquired a new stake in shares of NutriSystem in the 2nd quarter valued at about $394,000.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 19th. Shareholders of record on Friday, November 9th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.00 dividend on an annualized basis and a yield of 2.66%. NutriSystem’s dividend payout ratio is currently 51.02%.
NutriSystem announced that its Board of Directors has initiated a share repurchase plan on Tuesday, October 30th that authorizes the company to repurchase $75.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 7.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
Further Reading: Fundamental Analysis and Individual Investors
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.